Jayant Iyer1,2, Jayme R Vianna3, Balwantray C Chauhan3, Harry A Quigley1. 1. Glaucoma Center of Excellence, Wilmer Institute, Johns Hopkins, Baltimore, Maryland, USA. 2. Singapore National Eye Centre, Singapore, Singapore. 3. Department of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada.
Abstract
PURPOSE OF REVIEW: A process is ongoing to produce a definition of glaucomatous optic neuropathy (GON) using quantitative, objective data from structural and functional tests. At present, a common practice is to define GON by subjective features said to be 'characteristic' as judged by those experienced in glaucoma care. RECENT FINDINGS: An objective definition would standardize the comparison of clinical research results across studies, without precluding simultaneous use of idiosyncratic definitions in the same reports. To achieve this goal, expert opinion was solicited to reach optimal agreement on one or more consensus, GON definitions. An interactive period of online discussion by 176 international experts led to 110 responses in an online survey that narrowed possible definitional structures into testable criteria. SUMMARY: Two approaches to validation of one or more sets of criteria for definite and possible GON are ongoing. The general principles include definition for each eye individually, inclusion of a borderline category, no intraocular pressure criterion, and both structural and functional defects in appropriate physical locations. Each validation approach uses clinician diagnosis as a standard against which objective criteria are compared, with the initial approach using a three-level categorical scale, and the second approach using 0--100 scaling.
PURPOSE OF REVIEW: A process is ongoing to produce a definition of glaucomatous optic neuropathy (GON) using quantitative, objective data from structural and functional tests. At present, a common practice is to define GON by subjective features said to be 'characteristic' as judged by those experienced in glaucoma care. RECENT FINDINGS: An objective definition would standardize the comparison of clinical research results across studies, without precluding simultaneous use of idiosyncratic definitions in the same reports. To achieve this goal, expert opinion was solicited to reach optimal agreement on one or more consensus, GON definitions. An interactive period of online discussion by 176 international experts led to 110 responses in an online survey that narrowed possible definitional structures into testable criteria. SUMMARY: Two approaches to validation of one or more sets of criteria for definite and possible GON are ongoing. The general principles include definition for each eye individually, inclusion of a borderline category, no intraocular pressure criterion, and both structural and functional defects in appropriate physical locations. Each validation approach uses clinician diagnosis as a standard against which objective criteria are compared, with the initial approach using a three-level categorical scale, and the second approach using 0--100 scaling.
Authors: Jeffrey M Liebmann; Donald C Hood; Carlos Gustavo de Moraes; Dana M Blumberg; Noga Harizman; Yocheved S Kresch; Emmanouil Tsamis; George A Cioffi Journal: J Glaucoma Date: 2022-02-28 Impact factor: 2.290
Authors: Joel S Schuman; Maria De Los Angeles Ramos Cadena; Rebecca McGee; Lama A Al-Aswad; Felipe A Medeiros Journal: Ophthalmol Glaucoma Date: 2021-12-22
Authors: Eduardo B Mariottoni; Alessandro A Jammal; Samuel I Berchuck; Leonardo S Shigueoka; Ivan M Tavares; Felipe A Medeiros Journal: Sci Rep Date: 2021-01-18 Impact factor: 4.379
Authors: Janelle Tong; Jack Phu; David Alonso-Caneiro; Sieu K Khuu; Michael Kalloniatis Journal: Transl Vis Sci Technol Date: 2022-04-01 Impact factor: 3.048
Authors: Donald C Hood; Abinaya A Thenappan; Emmanouil Tsamis; Jeffrey M Liebmann; C Gustavo De Moraes Journal: Am J Ophthalmol Date: 2020-08-07 Impact factor: 5.258
Authors: Anita K Ghosh; Vidhya R Rao; Victoria J Wisniewski; Alexandra D Zigrossi; Jamie Floss; Peter Koulen; Evan B Stubbs; Simon Kaja Journal: Antioxidants (Basel) Date: 2020-04-16